请登录
搜索 英文站
栏目

提醒成功

请输入手机号/邮箱号
请输入密码

账号密码登录

微信/QQ登录 微信/QQ登录

没有账号? 立即注册

搜索
Rabbit Polyclonal Antibody to BCL-2(Ab-56)
Western blot analysis of extracts from Hela, A2780 and 293 cells using BCL-2(Ab-56) Antibody P41287.
Rabbit Polyclonal Antibody to BCL-2(Ab-56)
Immunofluorescence staining of methanol-fixed Hela cells using BCL-2(Ab-56) Antibody P41287.
Rabbit Polyclonal Antibody to BCL-2(Ab-56)
Immunohistochemical analysis of paraffin-embedded human breast carcinoma tissue using BCL-2(Ab-56) Antibody P41287(left) or the same antibody preincubated with blocking peptide(right).
Rabbit Polyclonal Antibody to BCL-2(Ab-56)
Rabbit Polyclonal Antibody to BCL-2(Ab-56)
Rabbit Polyclonal Antibody to BCL-2(Ab-56)

Rabbit Polyclonal Antibody to BCL-2(Ab-56)

  • 货号:

    P41287
  • 别名:

    BCL2
  • 产品上架时间:

    2024-01-01
  • 应用:

    WB,IHC,IF
  • 反应种属:

    Human
  • 抗体类型:

    Primary antibody
  • Swissprot:

    P10415
  • 规格:

  • 数量:

    -
    +
  • 说明书:

    目录价¥1980

加入购物车

Rabbit Polyclonal Antibody to BCL-2(Ab-56)

Description

Suppresses apoptosis in a variety of cell systems including factor-dependent lymphohematopoietic and neural cells. Regulates cell death by controlling the mitochondrial membrane permeability. Appears to function in a feedback loop system with caspases. Inhibits caspase activity either by preventing the release of cytochrome c from the mitochondria and/or by binding to the apoptosis-activating factor (APAF-1).

References

Ling, Y. H. et al. (1998) J. Biol. Chem. 273, 18984-18991.Huang, S.J. and Cidlowski, J.A. (2002) FASEB 16, 825-832.Deng, X. et al. (2001) J. Biol. Chem. 276, 23681-23688.Huang ST,et al. (2002) FASEB J Jun; 16(8): 825-32.Yamamoto, K. et al. (1999) Mol. Cell. Biol. 19, 8469-8478.

Specification

Aliases BCL2
Entrez GeneID 596;
Swissprot P10415
WB Predicted band size 26kDa
Host/Isotype Rabbit IgG
Antibody Type Primary antibody
Storage Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species Reactivity Human
Immunogen Peptide sequence around aa. 54~58 (G-H-T-P-H) derived from Human BCL-2.
Formulation Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

Application

WB 1/500-1/1000
IHC 1/50-1/100
IF/ICC 1/100-1/200